#BC3A/*$@=JNN[6*;8H$?Q&;-BX6XBE;X3Q?KRT_K~R_PQ5
SYSTEM PROCESSING...
#BC3A/*$@=JNN[6*;8H$?Q&;-BX6XBE;X3Q?KRT_K~R_PQ5
SYSTEM PROCESSING...
Posted: 2025-05-20 17:01:57 UTC
This article contains some claims that are falsified. While not everything in the article is false, please proceed with extreme caution and verify any critical information independently.
This article contains some claims that are falsified. While not everything in the article is false, please proceed with extreme caution and verify any critical information independently.
Status
Last Updated
2025-05-20 17:04:06 UTC
Verified By
Rollup News
The first patient treated with a prime edited therapeutic shows positive clinical outcomes consistent with effective rescue of his chronic granulomatous disease (CGD). There are at least 19 base editing and prime editing clinical trials have begun, with at least 7 trials reporting clinical outcomes. More base editing and prime editing clinical trials serving patients outside of the U.S. (13) than within the U.S. (9), despite the fact that these technologies were developed in our lab in the U.S.
First patient treated with prime editing shows positive clinical outcomes for chronic granulomatous disease (CGD).
At least 19 base editing and prime editing clinical trials have begun.
More clinical trials are being conducted outside the U.S. than within the U.S., despite the technology originating in the U.S.
U.S. support for science is now in crisis.
More base editing and prime editing clinical trials serving patients outside of the U.S. (13) than within the U.S. (9), despite the fact that these technologies were developed in our lab in the U.S.